Citations (123)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (18)
Ennio Lubrano, Michele Maria Luchetti, Devis Benfaremo, Daniele Mauro, Francesco Ciccia & Fabio Massimo Perrotta. (2021) Inflammatory bowel disease manifestations in spondyloarthritis: considerations for the clinician. Expert Review of Clinical Immunology 17:11, pages 1199-1209.
Read now
Read now
Johanna Engström, Maria Lönnkvist, Ragnar Befrits, Tryggve Ljung, Hetzel Diaz-Tartera, Mikael Holst & Per M. Hellström. (2019) Comparison of fecal calprotectin and serum C-reactive protein in early prediction of outcome to infliximab induction therapy. Scandinavian Journal of Gastroenterology 54:9, pages 1081-1088.
Read now
Read now
Christopher Ma, Robert Battat, Claire E. Parker, Reena Khanna, Vipul Jairath & Brian Gordon Feagan. (2019) Update on C-reactive protein and fecal calprotectin: are they accurate measures of disease activity in Crohn’s disease?. Expert Review of Gastroenterology & Hepatology 13:4, pages 319-330.
Read now
Read now
Tero Ylisaukko-oja, Jaakko Aaltonen, Heikki Nuutinen, Timo Blomster, Airi Jussila, Markku Pajala, Kimmo Salminen, Veikko Moilanen, Kalle Hakala, Mikko Kellokumpu, Kari Toljamo, Henna Rautiainen, Juha Kuisma, Markku Peräaho, Pauliina Molander, Jouni Silvennoinen, Ville Liukkonen, Hans Henricson, Jyrki Tillonen, Mirva Esterinen, Christian Nielsen, Eija Hirsi, Margus Lääne, Ulla-Maija Suhonen, Ilkka Vihriälä, Petri Mäkelä, Mika Puhto, Jari Punkkinen, Hannu Sulonen, Sauli Herrala, Jari Jokelainen, Klaus Tamminen & Taina Sipponen. (2018) High treatment persistence rate and significant endoscopic healing among real-life patients treated with vedolizumab – a Finnish Nationwide Inflammatory Bowel Disease Cohort Study (FINVEDO). Scandinavian Journal of Gastroenterology 53:2, pages 158-167.
Read now
Read now
Károly Palatka, Sándor Kacska, Szilvia Lovas, Ildikó Garai, József Varga & László Galuska. (2018) The potential role of FDG PET-CT in the characterization of the activity of Crohn’s disease, staging follow-up and prognosis estimation: a pilot study. Scandinavian Journal of Gastroenterology 53:1, pages 24-30.
Read now
Read now
Gerard Cummins, Diana E. Yung, Ben F. Cox, Anastasios Koulaouzidis, Marc P. Y. Desmulliez & Sandy Cochran. (2017) Luminally expressed gastrointestinal biomarkers. Expert Review of Gastroenterology & Hepatology 11:12, pages 1119-1134.
Read now
Read now
Paula Ministro & Diana Martins. (2017) Fecal biomarkers in inflammatory bowel disease: how, when and why?. Expert Review of Gastroenterology & Hepatology 11:4, pages 317-328.
Read now
Read now
Maureen C. Turina, Robert Landewé & Dominique Baeten. (2017) Lessons to be learned from serum biomarkers in psoriasis and IBD – the potential role in SpA. Expert Review of Clinical Immunology 13:4, pages 333-344.
Read now
Read now
Krisztina B. Gecse, Johannan F. Brandse, Sandra van Wilpe, Mark Löwenberg, Cyriel Ponsioen, Gijs van den Brink & Geert D’Haens. (2015) Impact of disease location on fecal calprotectin levels in Crohn’s disease. Scandinavian Journal of Gastroenterology 50:7, pages 841-847.
Read now
Read now
Morten H. Vatn & Arne K. Sandvik. (2015) Inflammatory bowel disease. Scandinavian Journal of Gastroenterology 50:6, pages 748-762.
Read now
Read now
Takayuki Yamamoto. (2015) Diagnosis and monitoring of postoperative recurrence in Crohn’s disease. Expert Review of Gastroenterology & Hepatology 9:1, pages 55-66.
Read now
Read now
Renata D’Incà & Roberta Caccaro. (2014) Measuring disease activity in Crohn’s disease: what is currently available to the clinician. Clinical and Experimental Gastroenterology 7, pages 151-161.
Read now
Read now
Emanuel Burri & Christoph Beglinger. (2014) The use of fecal calprotectin as a biomarker in gastrointestinal disease. Expert Review of Gastroenterology & Hepatology 8:2, pages 197-210.
Read now
Read now
Roberta Caccaro, Renata D’Incà, Surajit Pathak & Giacomo Carlo Sturniolo. (2012) Clinical utility of calprotectin and lactoferrin in patients with inflammatory bowel disease: is there something new from the literature?. Expert Review of Clinical Immunology 8:6, pages 579-585.
Read now
Read now
Clas-Göran af Björkesten, Urpo Nieminen, Ulla Turunen, Perttu Arkkila, Taina Sipponen & Martti Färkkilä. (2012) Surrogate markers and clinical indices, alone or combined, as indicators for endoscopic remission in anti-TNF-treated luminal Crohn's disease. Scandinavian Journal of Gastroenterology 47:5, pages 528-537.
Read now
Read now
Carl G. Persson & Lena Uller. (2011) Increased fecal leukocytes may reflect resolution of IBD. Scandinavian Journal of Gastroenterology 46:2, pages 251-252.
Read now
Read now
Roberta Caccaro, Renata D’Incá & Giacomo Carlo Sturniolo. (2010) Clinical utility of calprotectin and lactoferrin as markers of inflammation in patients with inflammatory bowel disease. Expert Review of Clinical Immunology 6:4, pages 551-558.
Read now
Read now
. (2010) This month in Scandinavian Journal of Gastroenterology. Scandinavian Journal of Gastroenterology 45:3, pages 259-260.
Read now
Read now
Articles from other publishers (105)
Yoshihiro Tatsumi, Kazuki Kakimoto, Azusa Hara, Noboru Mizuta, Keijiro Numa, Naohiko Kinoshita, Kei Nakazawa, Ryoji Koshiba, Yuki Hirata, Kazuhiro Ota, Takako Miyazaki, Shiro Nakamura, Kayoko Sakagami, Shoko Arimitsu, Hiroaki Ito & Hiroki Nishikawa. (2023) Biomarkers for Monitoring of Changes in Disease Activity in Ulcerative Colitis. Journal of Clinical Medicine 12:22, pages 7165.
Crossref
Crossref
Runqiu Wu, Jin Yang, Jinjin Cao, Peng Wang, Chenhui Wang, Wenxin Chen, Yanling Wu, Xinguo Zheng, Yu Jin & Hui Yang. (2023) Efficacy of short-chain polypeptide-based EEN formulas in alleviating intestinal injury in children with Crohn’s disease: a single-center study in China. Frontiers in Nutrition 10.
Crossref
Crossref
Kailee A Zornow, Jennifer E Slovak, Jonathan A Lidbury, Jan S Suchodolski & Joerg M Steiner. (2023) Fecal S100A12 concentrations in cats with chronic enteropathies. Journal of Feline Medicine and Surgery 25:3, pages 1098612X2311642.
Crossref
Crossref
Lingjia Kong, Vladislav Pokatayev, Ariel Lefkovith, Grace T. Carter, Elizabeth A. Creasey, Chirag Krishna, Sathish Subramanian, Bharati Kochar, Orr Ashenberg, Helena Lau, Ashwin N. Ananthakrishnan, Daniel B. Graham, Jacques Deguine & Ramnik J. Xavier. (2023) The landscape of immune dysregulation in Crohn’s disease revealed through single-cell transcriptomic profiling in the ileum and colon. Immunity 56:2, pages 444-458.e5.
Crossref
Crossref
Suleyman Demiryas & Anıl Orhan. 2022. Biomarkers in Medicine. Biomarkers in Medicine
407
424
.
Jacob E. Ollech, Lian Bannon, Nitsan Maharshak, Nir Bar, Idan Goren, Hagit Tulchinsky, Henit Yanai & Iris Dotan. (2022) Fecal Calprotectin Is Increased in Pouchitis and Progressively Increases With More Severe Endoscopic and Histologic Disease. Clinical Gastroenterology and Hepatology 20:8, pages 1839-1846.e2.
Crossref
Crossref
Yeoun Joo Lee & Jae Hong Park. (2022) Fecal Calprotectin Assay at an Early Stage of Treatment Can Be Used as a Surrogate Marker to Predict Clinical Remission and Mucosal Healing in Pediatric Crohn’s Disease. Pediatric Gastroenterology, Hepatology & Nutrition 25:5, pages 396.
Crossref
Crossref
Fang Chen, Yue Hu, Yi-Hong Fan & Bin Lv. (2021) Clinical Value of Fecal Calprotectin in Predicting Mucosal Healing in Patients With Ulcerative Colitis. Frontiers in Medicine 8.
Crossref
Crossref
M.S. Ismail, Serhiy Semenov & Deirdre McNamara. (2021) The utility of faecal and urine biomarkers for small bowel diseases. Current Opinion in Gastroenterology 37:3, pages 284-294.
Crossref
Crossref
Rosanna Cannatelli, Alina Bazarova, Davide Zardo, Olga Maria Nardone, Uday Shivaji, Samuel Charles Lloyd Smith, Georgios Gkoutos, Chiara Ricci, Xianyong Sean Gui, Subrata Ghosh & Marietta Iacucci. (2021) Fecal Calprotectin Thresholds to Predict Endoscopic Remission Using Advanced Optical Enhancement Techniques and Histological Remission in IBD Patients. Inflammatory Bowel Diseases 27:5, pages 647-654.
Crossref
Crossref
Filippo Vernia, Angelo Viscido, Mirko Di Ruscio, Gianpiero Stefanelli, Marco Valvano & Giovanni Latella. (2021) Fecal Lactoferrin and Other Putative Fecal Biomarkers in Crohn’s Disease: Do They Still Have a Potential Clinical Role?. Digestion 102:6, pages 833-844.
Crossref
Crossref
TETSUSHI KINUGASA, KEIICHI MITSUYAMA, KENTA MUROTANI, TOMOAKI MIZOBE, TAKAFUMI OCHI, TETSUHIRO YOSHIMURA, KOUTAROU KUWAKI, TARO ISOBE & YOSHITO AKAGI. (2020) Non-invasive Monitoring of Pouchitis After Total Proctocolectomy Using Fecal Calprotectin Levels. The Kurume Medical Journal 67:2.3, pages 57-63.
Crossref
Crossref
Małgorzata Krzystek-Korpacka, Radosław Kempiński, Mariusz Bromke & Katarzyna Neubauer. (2020) Biochemical Biomarkers of Mucosal Healing for Inflammatory Bowel Disease in Adults. Diagnostics 10:6, pages 367.
Crossref
Crossref
Filippo Vernia, Mirko Di Ruscio, Gianpiero Stefanelli, Angelo Viscido, Giuseppe Frieri & Giovanni Latella. (2019) Is fecal calprotectin an accurate marker in the management of Crohn's disease?. Journal of Gastroenterology and Hepatology 35:3, pages 390-400.
Crossref
Crossref
Lorant Gonczi, Talat Bessissow & Peter Laszlo Lakatos. (2019) Disease monitoring strategies in inflammatory bowel diseases: What do we mean by ‘tight control’?. World Journal of Gastroenterology 25:41, pages 6172-6189.
Crossref
Crossref
Anneline Cremer, Jade Ku, Leila Amininejad, Marie-Rose Bouvry, Fabian Brohet, Claire Liefferinckx, Jacques Devière, André van Gossum, Julie Smet, Patrick Stordeur & Denis Franchimont. (2019) Variability of Faecal Calprotectin in Inflammatory Bowel Disease Patients: An Observational Case-control Study. Journal of Crohn's and Colitis 13:11, pages 1372-1379.
Crossref
Crossref
Elena Cerrillo, Inés Moret, Marisa Iborra, José Pamies, David Hervás, Luis Tortosa, Esteban Sáez-González, Pilar Nos & Belén Beltrán. (2019) A Nomogram Combining Fecal Calprotectin Levels and Plasma Cytokine Profiles for Individual Prediction of Postoperative Crohn’s Disease Recurrence. Inflammatory Bowel Diseases 25:10, pages 1681-1691.
Crossref
Crossref
Devis Benfaremo, Michele Maria Luchetti & Armando Gabrielli. (2019) Biomarkers in Inflammatory Bowel Disease-Associated Spondyloarthritis: State of the Art and Unmet Needs. Journal of Immunology Research 2019, pages 1-10.
Crossref
Crossref
Christopher R. Lindholm & Corey A. Siegel. (2019) Are We Ready to Include Prognostic Factors in Inflammatory Bowel Disease Trials?. Current Pharmaceutical Design 25:1, pages 64-68.
Crossref
Crossref
Christopher Ma, Robert Battat, Reena Khanna, Claire E. Parker, Brian G. Feagan & Vipul Jairath. (2019) What is the role of C-reactive protein and fecal calprotectin in evaluating Crohn's disease activity?. Best Practice & Research Clinical Gastroenterology 38-39, pages 101602.
Crossref
Crossref
Yang Woon Lee, Kang-Moon Lee, Ji Min Lee, Yoon Yung Chung, Dae Bum Kim, Yeon Ji Kim, Woo Chul Chung & Chang-Nyol Paik. (2019) The usefulness of fecal calprotectin in assessing inflammatory bowel disease activity. The Korean Journal of Internal Medicine 34:1, pages 72-80.
Crossref
Crossref
Amanda M. Lynn & Edward V. LoftusJrJr. 2019. Biomarkers in Inflammatory Bowel Diseases. Biomarkers in Inflammatory Bowel Diseases
57
71
.
Petra Weimers, Dorit Vedel Ankersen & Pia Munkholm. 2019. Biomarkers in Inflammatory Bowel Diseases. Biomarkers in Inflammatory Bowel Diseases
271
278
.
Catherine Reenaers, Peter Bossuyt, Pieter Hindryckx, Hilde Vanpoucke, Anneline Cremer & Filip Baert. (2018) Expert opinion for use of faecal calprotectin in diagnosis and monitoring of inflammatory bowel disease in daily clinical practice. United European Gastroenterology Journal 6:8, pages 1117-1125.
Crossref
Crossref
Jordi Guardiola, Triana Lobatón, Elena Cerrillo, Rocío Ferreiro-Iglesias, Javier P. Gisbert, Eugeni Domènech, María Chaparro, Maria Esteve & Francisco Rodríguez-Moranta. (2018) Recomendaciones del Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa (GETECCU) sobre la utilidad de la determinación de calprotectina fecal en la enfermedad inflamatoria intestinal. Gastroenterología y Hepatología 41:8, pages 514-529.
Crossref
Crossref
Jordi Guardiola, Triana Lobatón, Elena Cerrillo, Rocío Ferreiro-Iglesias, Javier P. Gisbert, Eugeni Domènech, María Chaparro, Maria Esteve & Francisco Rodríguez-Moranta. (2018) Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on the utility of the determination of faecal calprotectin in inflammatory bowel disease. Gastroenterología y Hepatología (English Edition) 41:8, pages 514-529.
Crossref
Crossref
Eran Zittan, Orlaith B Kelly, Ian M Gralnek, Mark S Silverberg & A Hillary Steinhart. (2018) Fecal calprotectin correlates with active colonic inflammatory bowel disease but not with small intestinal Crohn's disease activity. JGH Open 2:5, pages 201-206.
Crossref
Crossref
Tsvetelina Veselinova Velikova, Zoya Angelova Spassova, Lyuben Mitkov Milatchkov, Dobriana Georgieva Panova, Ekaterina Ivanova Ivanova - Todorova, Kalina Dinkova Tumangelova - Yuzeir, Ekaterina Krasimirova Kurteva, Dobroslav Stanimirov Kyurkchiev, Siragan Arshavir Deredjan, Rosen Kirilov Nikolov, Iskra Petrova Altankova & Lyudmila Mateva Vladimirova. (2018) Dynamics of Some Routine Immunological Parameters During Anti - TNF Therapy in Patients with Crohn’s Disease. Annals of Colorectal Research 6:1.
Crossref
Crossref
Marc W Morris, Samuel A Stewart, Courtney Heisler, William J Sandborn, Edward V Loftus, Gordon A Zello, Sharyle A Fowler & Jennifer L Jones. (2018) Biomarker-Based Models Outperform Patient-Reported Scores in Predicting Endoscopic Inflammatory Disease Activity. Inflammatory Bowel Diseases 24:2, pages 277-285.
Crossref
Crossref
Vipul Aggarwal, Andrew S. Day, Susan Connor, Steven T. Leach, Gregor Brown, Rajvinder Singh, Antony Friedman, Amany Zekry & Philip I. Craig. (2017) Role of capsule endoscopy and fecal biomarkers in small-bowel Crohn's disease to assess remission and predict relapse. Gastrointestinal Endoscopy 86:6, pages 1070-1078.
Crossref
Crossref
Christopher Ma, Rowan Lumb, Emily V. Walker, Rae R. Foshaug, ThucNhi T. Dang, Sanam Verma, Vivian W. Huang, Karen I. Kroeker, Karen Wong, Levinus A. Dieleman, Richard N. Fedorak & Brendan P. Halloran. (2017) Noninvasive Fecal Immunochemical Testing and Fecal Calprotectin Predict Mucosal Healing in Inflammatory Bowel Disease. Inflammatory Bowel Diseases 23:9, pages 1643-1649.
Crossref
Crossref
Séverine Vermeire, William J Sandborn, Silvio Danese, Xavier Hébuterne, Bruce A Salzberg, Maria Klopocka, Dino Tarabar, Tomas Vanasek, Miloš Greguš, Paul A Hellstern, Joo Sung Kim, Miles P Sparrow, Kenneth J Gorelick, Michelle Hinz, Alaa Ahmad, Vivek Pradhan, Mina Hassan-Zahraee, Robert Clare, Fabio Cataldi & Walter Reinisch. (2017) Anti-MAdCAM antibody (PF-00547659) for ulcerative colitis (TURANDOT): a phase 2, randomised, double-blind, placebo-controlled trial. The Lancet 390:10090, pages 135-144.
Crossref
Crossref
Dan Turner, Arie Levine, Thomas D. Walters, Gili Focht, Anthony Otley, Victor Navas López, Sibylle Koletzko, Robert Baldassano, David Mack, Jeffrey Hyams & Anne M. Griffiths. (2017) Which PCDAI Version Best Reflects Intestinal Inflammation in Pediatric Crohn Disease?. Journal of Pediatric Gastroenterology & Nutrition 64:2, pages 254-260.
Crossref
Crossref
Juan María Vázquez Morón, Héctor Pallarés Manrique, Francisco H. Machancoses, Manuel Ramos Lora & Carlos Ruíz Frutos. (2017) Accurate cut-offs for predicting endoscopic activity and mucosal healing in Crohns disease with fecal calprotectin. Revista Española de Enfermedades Digestivas 109.
Crossref
Crossref
Liran Domachevsky, Haim Leibovitzh, Irit Avni-Biron, Lev Lichtenstein, Natalia Goldberg, Meital Nidam, David Groshar, Hanna Bernstine & Ofer Ben-Bassat. (2017) Correlation of 18F-FDG PET/MRE Metrics with Inflammatory Biomarkers in Patients with Crohn’s Disease: A Pilot Study. Contrast Media & Molecular Imaging 2017, pages 1-9.
Crossref
Crossref
J.K. Yamamoto-Furusho, F. Bosques-Padilla, J. de-Paula, M.T. Galiano, P. Ibañez, F. Juliao, P.G. Kotze, J.L. Rocha, F. Steinwurz, G. Veitia & C. Zaltman. (2017) Diagnosis and treatment of inflammatory bowel disease: First Latin American Consensus of the Pan American Crohn's and Colitis Organisation. Revista de Gastroenterología de México (English Edition) 82:1, pages 46-84.
Crossref
Crossref
J.K. Yamamoto-Furusho, F. Bosques-Padilla, J. de-Paula, M.T. Galiano, P. Ibañez, F. Juliao, P.G. Kotze, J.L. Rocha, F. Steinwurz, G. Veitia & C. Zaltman. (2017) Diagnóstico y tratamiento de la enfermedad inflamatoria intestinal: Primer Consenso Latinoamericano de la Pan American Crohn's and Colitis Organisation. Revista de Gastroenterología de México 82:1, pages 46-84.
Crossref
Crossref
Brinda Tammara, Sangeeta Raje, William McKeand & Joan M. Korth-Bradley. 2017. Translating Molecules into Medicines. Translating Molecules into Medicines
341
372
.
Britt Christensen & David T. Rubin. 2017. Crohn's Disease and Ulcerative Colitis. Crohn's Disease and Ulcerative Colitis
267
277
.
Edward L. Barnes & Robert Burakoff. (2016) New Biomarkers for Diagnosing Inflammatory Bowel Disease and Assessing Treatment Outcomes. Inflammatory Bowel Diseases 22:12, pages 2956-2965.
Crossref
Crossref
Alissa J. Walsh, Robert V. Bryant & Simon P. L. Travis. (2016) Current best practice for disease activity assessment in IBD. Nature Reviews Gastroenterology & Hepatology 13:10, pages 567-579.
Crossref
Crossref
Parakkal Deepak, Joel G. Fletcher, Jeff L. Fidler & David H. Bruining. (2016) Computed Tomography and Magnetic Resonance Enterography in Crohnʼs Disease. Inflammatory Bowel Diseases 22:9, pages 2280-2288.
Crossref
Crossref
Reena Khanna, Sigrid A Nelson, Brian G Feagan, Geert D'Haens, William J Sandborn, GY Zou, John K MacDonald, Claire E Parker, Vipul Jairath & Barrett G Levesque. (2016) Endoscopic scoring indices for evaluation of disease activity in Crohn’s disease. Cochrane Database of Systematic Reviews 2016:8.
Crossref
Crossref
Toshihiro Inokuchi, Jun Kato, Sakiko Hiraoka, Shiho Takashima, Asuka Nakarai, Daisuke Takei, Yuusaku Sugihara, Masahiro Takahara, Seiji Kawano, Keita Harada & Hiroyuki Okada. (2016) Fecal Immunochemical Test Versus Fecal Calprotectin for Prediction of Mucosal Healing in Crohnʼs Disease. Inflammatory Bowel Diseases 22:5, pages 1078-1085.
Crossref
Crossref
Emily K. Wright, Michael A. Kamm, Peter De Cruz, Amy L. Hamilton, Kathryn J. Ritchie, Jacqueline I. Keenan, Steven Leach, Laura Burgess, Alan Aitchison, Alexandra Gorelik, Danny Liew, Andrew S. Day & Richard B. Gearry. (2016) Comparison of Fecal Inflammatory Markers in Crohnʼs Disease. Inflammatory Bowel Diseases 22:5, pages 1086-1094.
Crossref
Crossref
Eran Zittan, Orlaith B. Kelly, Richard Kirsch, Raquel Milgrom, Jane Burns, Geoffrey C. Nguyen, Ken Croitoru, Gert Van Assche, Mark S. Silverberg & A. Hillary Steinhart. (2016) Low Fecal Calprotectin Correlates with Histological Remission and Mucosal Healing in Ulcerative Colitis and Colonic Crohnʼs Disease. Inflammatory Bowel Diseases 22:3, pages 623-630.
Crossref
Crossref
Louise E. Britton, Joseph P. Cassidy, Jim O'Donovan, Stephen V. Gordon & Bryan Markey. (2016) Potential application of emerging diagnostic techniques to the diagnosis of bovine Johne's disease (paratuberculosis). The Veterinary Journal 209, pages 32-39.
Crossref
Crossref
Carlos Teruel. (2016) Diagnosis and management of functional symptoms in inflammatory bowel disease in remission. World Journal of Gastrointestinal Pharmacology and Therapeutics 7:1, pages 78.
Crossref
Crossref
Patrick PY Chan. (2016) Current application of proteomics in biomarker discovery for inflammatory bowel disease. World Journal of Gastrointestinal Pathophysiology 7:1, pages 27.
Crossref
Crossref
Elisa Liverani. (2016) How to predict clinical relapse in inflammatory bowel disease patients. World Journal of Gastroenterology 22:3, pages 1017.
Crossref
Crossref
Britt Christensen & David T. Rubin. (2016) Understanding Endoscopic Disease Activity in IBD: How to Incorporate It into Practice. Current Gastroenterology Reports 18:1.
Crossref
Crossref
Johan Burisch & Pia Munkholm. 2016. Telemanagement of Inflammatory Bowel Disease. Telemanagement of Inflammatory Bowel Disease
85
99
.
Anke Heida, Alie Dijkstra, Henk Groen, Anneke Muller Kobold, Henkjan Verkade & Patrick van Rheenen. (2015) Comparing the efficacy of a web-assisted calprotectin-based treatment algorithm (IBD-live) with usual practices in teenagers with inflammatory bowel disease: study protocol for a randomized controlled trial. Trials 16:1.
Crossref
Crossref
Bruce E. Sands. (2015) Biomarkers of Inflammation in Inflammatory Bowel Disease. Gastroenterology 149:5, pages 1275-1285.e2.
Crossref
Crossref
Katarzyna Klimczak, Liliana Lykowska-Szuber, Piotr Eder, Iwona Krela-Kazmierczak, Kamila Stawczyk-Eder, Aleksandra Szymczak, Michal Michalak, Adam Studniarek & Krzysztof Linke. (2015) The diagnostic usefulness of fecal lactoferrin in the assessment of Crohn's disease activity. European Journal of Internal Medicine 26:8, pages 623-627.
Crossref
Crossref
Takayuki Yamamoto, Takahiro Shimoyama, Takuya Bamba & Koichi Matsumoto. (2015) Consecutive Monitoring of Fecal Calprotectin and Lactoferrin for the Early Diagnosis and Prediction of Pouchitis after Restorative Proctocolectomy for Ulcerative Colitis. American Journal of Gastroenterology 110:6, pages 881-887.
Crossref
Crossref
Emilie Viennois, Yuan Zhao & Didier Merlin. (2015) Biomarkers of Inflammatory Bowel Disease. Inflammatory Bowel Diseases, pages 1.
Crossref
Crossref
Margalida Calafat, Eduard Cabré, Míriam Mañosa, Triana Lobatón, Laura Marín & Eugeni Domènech. (2015) High Within-day Variability of Fecal Calprotectin Levels in Patients with Active Ulcerative Colitis. Inflammatory Bowel Diseases 21:5, pages 1072-1076.
Crossref
Crossref
Antonio Tursi, Walter Elisei, Marcello Picchio, GianMarco Giorgetti & Giovanni Brandimarte. (2014) Accuracy of Rapid Fecal Calprotectin Test in Monitoring Inflammatory Bowel Diseases Under Treatment with TNFα Antagonists. Digestive Diseases and Sciences 60:5, pages 1406-1413.
Crossref
Crossref
Emanuel Burri, Christoph Beglinger, Stefanie von Felten & Frank Serge Lehmann. (2014) Fecal Calprotectin and the Clinical Activity Index Are Both Useful to Monitor Medical Treatment in Patients with Ulcerative Colitis. Digestive Diseases and Sciences 60:2, pages 485-491.
Crossref
Crossref
Gudula JAM Boon. (2015) Are faecal markers good indicators of mucosal healing in inflammatory bowel disease?. World Journal of Gastroenterology 21:40, pages 11469.
Crossref
Crossref
Shannon Chang. (2015) Disease monitoring in inflammatory bowel disease. World Journal of Gastroenterology 21:40, pages 11246.
Crossref
Crossref
E. Louis. (2014) Fecal calprotectin: towards a standardized use for inflammatory bowel disease management in routine practice.. Journal of Crohn's and Colitis 9:1, pages 1-3.
Crossref
Crossref
Liliana-Elisabeta David, Teodora Surdea-Blaga & Dan-Lucian Dumitrascu. (2014) Semiquantitative fecal calprotectin test in postinfectious and non-postinfectious irritable bowel syndrome: cross-sectional study. Sao Paulo Medical Journal 133:4, pages 343-349.
Crossref
Crossref
David B. Sachar. (2014) Role of Biomarkers in the Study and Management of Inflammatory Bowel Disease. Inflammatory Bowel Diseases 20:12, pages 2511-2518.
Crossref
Crossref
Luisa Guidi, Manuela Marzo, Gianluca Andrisani, Carla Felice, Daniela Pugliese, Giammarco Mocci, Olga Nardone, Italo De Vitis, Alfredo Papa, Gianlodovico Rapaccini, Franca Forni & Alessandro Armuzzi. (2014) Faecal calprotectin assay after induction with anti-Tumour Necrosis Factor α agents in inflammatory bowel disease: Prediction of clinical response and mucosal healing at one year. Digestive and Liver Disease 46:11, pages 974-979.
Crossref
Crossref
Emily K. Wright, Peter De Cruz, Richard Gearry, Andrew S. Day & Michael A. Kamm. (2014) Fecal Biomarkers in the Diagnosis and Monitoring of Crohnʼs Disease. Inflammatory Bowel Diseases 20:9, pages 1668-1677.
Crossref
Crossref
Graham D. Naismith, Lyn A. Smith, Sarah J.E. Barry, Joanna I. Munro, Susan Laird, Karen Rankin, Allan J. Morris, Jack W. Winter & Daniel R. Gaya. (2014) A prospective evaluation of the predictive value of faecal calprotectin in quiescent Crohn's disease. Journal of Crohn's and Colitis 8:9, pages 1022-1029.
Crossref
Crossref
Jin-Feng Lin, Jin-Min Chen, Jun-Hua Zuo, Allen Yu, Zhu-Jun Xiao, Fei-Hong Deng, Biao Nie & Bo Jiang. (2014) Meta-analysis. Inflammatory Bowel Diseases 20:8, pages 1407-1415.
Crossref
Crossref
Geert R. D'Haens, R. Balfour Sartor, Mark S. Silverberg, Joel Petersson & Paul Rutgeerts. (2014) Future directions in inflammatory bowel disease management. Journal of Crohn's and Colitis 8:8, pages 726-734.
Crossref
Crossref
M. Prager & C. Büning. (2014) Klinik, CRP, Calprotectin, MRT oder Endoskopie?Clinical symptoms, C-reactive protein, calprotectin, MRI or endoscopy?. coloproctology 36:4, pages 250-258.
Crossref
Crossref
Christine Prell, Dorothea Nagel, Folke Freudenberg, Andrea Schwarzer & Sibylle Koletzko. (2014) Comparison of three tests for faecal calprotectin in children and young adults: a retrospective monocentric study. BMJ Open 4:5, pages e004558.
Crossref
Crossref
Mark E. Gerich & Dermot P. B. McGovern. (2013) Towards personalized care in IBD. Nature Reviews Gastroenterology & Hepatology 11:5, pages 287-299.
Crossref
Crossref
Uri Kopylov, Greg Rosenfeld, Brian Bressler & Ernest Seidman. (2014) Clinical Utility of Fecal Biomarkers for the Diagnosis and Management of Inflammatory Bowel Disease. Inflammatory Bowel Diseases 20:4, pages 742-756.
Crossref
Crossref
Takayuki Yamamoto, Manabu Shiraki, Takuya Bamba, Satoru Umegae & Koichi Matsumoto. (2013) Fecal calprotectin and lactoferrin as predictors of relapse in patients with quiescent ulcerative colitis during maintenance therapy. International Journal of Colorectal Disease 29:4, pages 485-491.
Crossref
Crossref
T. Klag, E.F. Stange & J. Wehkamp. (2014) Labordiagnostik bei chronisch-entzündlichen Darmerkrankungen, einschließlich Blut- und StuhldiagnostikBiomarkers for chronic inflammatory bowel diseases including blood and stool tests. Der Gastroenterologe 9:2, pages 117-126.
Crossref
Crossref
Jesica C. Makanyanga, Doug Pendsé, Nikolaos Dikaios, Stuart Bloom, Sara McCartney, Emma Helbren, Elaine Atkins, Terry Cuthbertson, Shonit Punwani, Alastair Forbes, Steve Halligan & Stuart A. Taylor. (2013) Evaluation of Crohn’s disease activity: Initial validation of a magnetic resonance enterography global score (MEGS) against faecal calprotectin. European Radiology 24:2, pages 277-287.
Crossref
Crossref
Bernhard Sauter, Christoph Beglinger, Marc Girardin, Andrew Macpherson, Pierre Michetti, Alain Schoepfer, Frank Seibold, Stephan R. Vavricka & Gerhard Rogler. (2014) Monitoring Disease Activity and Progression in Crohn's Disease. A Swiss Perspective on the IBD Ahead ‘Optimised Monitoring' Recommendations. Digestion 89:4, pages 299-309.
Crossref
Crossref
Yi Fengming & Wu Jianbing. (2014) Biomarkers of Inflammatory Bowel Disease. Disease Markers 2014, pages 1-11.
Crossref
Crossref
Jose-Manuel Benitez, Marie-Alice Meuwis, Catherine Reenaers, Catherine Van Kemseke, Paul Meunier & Edouard Louis. (2013) Role of endoscopy, cross-sectional imaging and biomarkers in Crohn's disease monitoring. Gut 62:12, pages 1806-1816.
Crossref
Crossref
T. Yamamoto & T. Watanabe. (2013) Strategies for the prevention of postoperative recurrence of Crohn's disease. Colorectal Disease 15:12, pages 1471-1480.
Crossref
Crossref
William A Faubion, Joel G Fletcher, Sharon O'Byrne, Brian G Feagan, Willem JS de Villiers, Bruce Salzberg, Scott Plevy, Deborah D Proctor, John F Valentine, Peter D Higgins, Jeffrey M Harris, Lauri Diehl, Lilyan Wright, Gaik Wei Tew, Diana Luca, Karen Basu & Mary E Keir. (2013) EMerging BiomARKers in Inflammatory Bowel Disease (EMBARK) Study Identifies Fecal Calprotectin, Serum MMP9, and Serum IL-22 as a Novel Combination of Biomarkers for Crohn's Disease Activity: Role of Cross-Sectional Imaging. American Journal of Gastroenterology 108:12, pages 1891-1900.
Crossref
Crossref
Triana Lobatón, Alicia López-García, Francisco Rodríguez-Moranta, Alexandra Ruiz, Lorena Rodríguez & Jordi Guardiola. (2013) A new rapid test for fecal calprotectin predicts endoscopic remission and postoperative recurrence in Crohn's disease. Journal of Crohn's and Colitis 7:12, pages e641-e651.
Crossref
Crossref
Takayuki Yamamoto, Manabu Shiraki, Takuya Bamba, Satoru Umegae & Koichi Matsumoto. (2013) Faecal calprotectin and lactoferrin as markers for monitoring disease activity and predicting clinical recurrence in patients with Crohn’s disease after ileocolonic resection: A prospective pilot study. United European Gastroenterology Journal 1:5, pages 368-374.
Crossref
Crossref
Martine De Vos, Edouard J. Louis, Jørgen Jahnsen, Jo G.P. Vandervoort, Maja Noman, Olivier Dewit, Geert R. DʼHaens, Denis Franchimont, Filip J. Baert, Roald A. Torp, Magne Henriksen, Philippe M.R. Potvin, Philippe P. Van Hootegem, Pieter M. Hindryckx, Tom G. Moreels, Arnaud Collard, Lars Normann Karlsen, Eirik Kittang, Guy Lambrecht, Tore Grimstad, Jonas Koch, Idar Lygren, Jean-Claude R.J. Coche, Fazia Mana, André Van Gossum, Jacques Belaiche, Mike R. Cool, Fernand Fontaine, Jean-Marc G. Maisin, Vinciane Muls, Bart Neuville, Dirk A. J. Staessen, Gert A. Van Assche, Thomas de Lange, Inger Camilla Solberg, Bert J.K. Vander Cruyssen & Severine A.R.A. Vermeire. (2013) Consecutive Fecal Calprotectin Measurements to Predict Relapse in Patients with Ulcerative Colitis Receiving Infliximab Maintenance Therapy. Inflammatory Bowel Diseases 19:10, pages 2111-2117.
Crossref
Crossref
Gerhard Rogler, Xavier Aldeguer, Wolfgang Kruis, Anders Lasson, Ulrich Mittmann, Ken Nally, Laurent Peyrin-Biroulet, Alain Schoepfer, Morten Vatn, Stephan Vavricka & Robert Logan. (2013) Concept for a rapid point-of-care calprotectin diagnostic test for diagnosis and disease activity monitoring in patients with inflammatory bowel disease: Expert clinical opinion. Journal of Crohn's and Colitis 7:8, pages 670-677.
Crossref
Crossref
Pavol Papay, Ana Ignjatovic, Konstantinos Karmiris, Heda Amarante, Pal Miheller, Brian Feagan, Geert D'Haens, Philippe Marteau, Walter Reinisch, Andreas Sturm, Flavio Steinwurz, Laurence Egan, Julián Panés, Edouard Louis, Jean-Frédéric Colombel & Remo Panaccione. (2013) Optimising monitoring in the management of Crohn's disease: A physician's perspective. Journal of Crohn's and Colitis 7:8, pages 653-669.
Crossref
Crossref
Ignazio Brusca. (2013) Biomarcatori nelle malattie infiammatorie intestinaliBiomarkers in inflammatory bowel disease. La Rivista Italiana della Medicina di Laboratorio - Italian Journal of Laboratory Medicine 9:3, pages 123-130.
Crossref
Crossref
Takayuki Yamamoto, Takuya Bamba, Satoru Umegae & Koichi Matsumoto. (2013) The impact of early endoscopic lesions on the clinical course of patients following ileocolonic resection for Crohn’s disease: A 5‐year prospective cohort study. United European Gastroenterology Journal 1:4, pages 294-298.
Crossref
Crossref
Francisco Rodríguez-Moranta, Triana Lobatón, Lorena Rodríguez-Alonso & Jordi Guardiola. (2013) Calprotectina fecal en el diagnóstico de enfermedades inflamatorias. Gastroenterología y Hepatología 36:6, pages 400-406.
Crossref
Crossref
Stephane Nancey, Gilles Boschetti, Driffa Moussata, Eddy Cotte, Julie Peyras, Charlotte Cuerq, Julie Haybrard, Anne-Laure Charlois, Anne Mialon, Marion Chauvenet, Karine Stroeymeyt, Dominique Kaiserlian, Jocelyne Drai & Bernard Flourié. (2013) Neopterin Is a Novel Reliable Fecal Marker as Accurate as Calprotectin for Predicting Endoscopic Disease Activity in Patients with Inflammatory Bowel Diseases. Inflammatory Bowel Diseases 19:5, pages 1043-1052.
Crossref
Crossref
Triana Lobatón, Francisco Rodríguez-Moranta, Alicia Lopez, Elena Sánchez, Lorena Rodríguez-Alonso & Jordi Guardiola. (2013) A New Rapid Quantitative Test for Fecal Calprotectin Predicts Endoscopic Activity in Ulcerative Colitis. Inflammatory Bowel Diseases 19:5, pages 1034-1042.
Crossref
Crossref
M. Prager & C. Büning. (2013) Klinik, CRP, Calprotectin, MRT oder Endoskopie?Clinical symptoms, C-reactive protein, calprotectin, MRI or endoscopy?. Der Gastroenterologe 8:3, pages 187-196.
Crossref
Crossref
Peter De Cruz, Michael A. Kamm, Lani Prideaux, Patrick B. Allen & Greg Moore. (2013) Mucosal Healing in Crohnʼs Disease. Inflammatory Bowel Diseases 19:2, pages 429-444.
Crossref
Crossref
Taina Sipponen. (2013) Diagnostics and Prognostics of Inflammatory Bowel Disease with Fecal Neutrophil-Derived Biomarkers Calprotectin and Lactoferrin. Digestive Diseases 31:3-4, pages 336-344.
Crossref
Crossref
Geert DʼHaens, Marc Ferrante, Severine Vermeire, Filip Baert, Maja Noman, Liesbeth Moortgat, Patricia Geens, Doreen Iwens, Isolde Aerden, Gert Van Assche, Gust Van Olmen & Paul Rutgeerts. (2012) Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease. Inflammatory Bowel Diseases 18:12, pages 2218-2224.
Crossref
Crossref
KL Kolho, D. Turner, G. Veereman-Wauters, M. Sladek, L. de Ridder, R. Shaoul, A. Paerregaard, J. Amil Dias, S. Koletzko, F. Nuti, Y. Bujanover, A. Staiano, K. Bochenek, L. Finnby, A. Levine & G. Veres. (2012) Rapid Test for Fecal Calprotectin Levels in Children With Crohn Disease. Journal of Pediatric Gastroenterology & Nutrition 55:4, pages 436-439.
Crossref
Crossref
Ron Shaoul, Marlgozata Sladek, Dan Turner, Anders Paeregaard, Gabor Veres, Gigi Veereman Wauters, Johanna Escher, Jorge Amil Dias, Paolo Lionetti, Annamaria Staino, Kaija Leena Kolho, Lissy de Ridder, Federica Nuti, Salvatore Cucchiara, Orit Sheva & Arie Levine. (2012) Limitations of Fecal Calprotectin At Diagnosis in Untreated Pediatric Crohnʼs Disease. Inflammatory Bowel Diseases 18:8, pages 1493-1497.
Crossref
Crossref
Vincent Billioud, Sébastien Gibot, Frédéric Massin, Abderrahim Oussalah, Jean-Baptiste Chevaux, Nicolas Williet, Jean-Pierre Bronowicki, Marc-André Bigard, Jean-Louis Guéant & Laurent Peyrin-Biroulet. (2012) Plasma soluble triggering receptor expressed on myeloid cells-1 in Crohn's disease. Digestive and Liver Disease 44:6, pages 466-470.
Crossref
Crossref
Heba N. Iskandar & Matthew A. Ciorba. (2012) Biomarkers in inflammatory bowel disease: current practices and recent advances. Translational Research 159:4, pages 313-325.
Crossref
Crossref
Anastasios Koulaouzidis, Sarah Douglas & John N. Plevris. (2011) Lewis Score Correlates More Closely with Fecal Calprotectin Than Capsule Endoscopy Crohn’s Disease Activity Index. Digestive Diseases and Sciences 57:4, pages 987-993.
Crossref
Crossref
Edouard Louis, Daniel C. Baumgart, Subrata Ghosh, Fernando Gomollón, Stephen Hanauer, Ailsa Hart & Peter Irving. (2012) What changes in inflammatory bowel disease management can be implemented today?. Journal of Crohn's and Colitis 6, pages S260-S267.
Crossref
Crossref
Julie Wassell, Michael Wallage & Ella Brewer. (2011)
Evaluation of the Quantum Blue
®
rapid test for faecal calprotectin
. Annals of Clinical Biochemistry: International Journal of Laboratory Medicine 49:1, pages 55-58.
Crossref
Crossref
D. Laharie, S. Mesli, F. El Hajbi, E. Chabrun, E. Chanteloup, M. Capdepont, S. Razaire, V. de Lédinghen & F. Zerbib. (2011) Prediction of Crohn’s disease relapse with faecal calprotectin in infliximab responders: a prospective study. Alimentary Pharmacology & Therapeutics 34:4, pages 462-469.
Crossref
Crossref
James D. Lewis. (2011) The Utility of Biomarkers in the Diagnosis and Therapy of Inflammatory Bowel Disease. Gastroenterology 140:6, pages 1817-1826.e2.
Crossref
Crossref